A detailed history of Perceptive Advisors LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 7,099,182 shares of VRCA stock, worth $56.4 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares
7,099,182
Previous 7,099,182 -0.0%
Holding current value
$56.4 Million
Previous $51.8 Million -0.0%
% of portfolio
1.5%
Previous 1.47%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$2.93 - $7.32 $6.04 Million - $15.1 Million
2,060,199 Added 40.89%
7,099,182 $52 Million
Q2 2022

Aug 15, 2022

BUY
$1.81 - $8.93 $2.59 Million - $12.8 Million
1,428,571 Added 39.57%
5,038,983 $9.68 Million
Q1 2021

May 17, 2021

BUY
$10.51 - $17.46 $2.1 Million - $3.49 Million
200,000 Added 5.86%
3,610,412 $54.7 Million
Q2 2018

Aug 14, 2018

BUY
$17.5 - $20.34 $59.7 Million - $69.4 Million
3,410,412 New
3,410,412 $67.3 Million

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.